Terms: = Head and neck cancer AND NCKIPSD, AF3P21, 51517, ENSG00000213672, SPIN90, WASLBP, Q9NZQ3, WISH, ORF1 AND Staging
3 results:
1. Phase II/III Randomized Controlled Trial of Concomitant Hyperfractionated Radiotherapy plus Cetuximab (Anti-EGFR Antibody) or Chemotherapy in Locally Advanced head and neck cancer.
Al-Saleh K; El-Sherify M; Safwat R; Elbasmy A; Shete J; Hussein A; Nazeeh M; Bedair A
Gulf J Oncolog; 2019 May; 1(30):6-12. PubMed ID: 31242976
[TBL] [Abstract] [Full Text] [Related]
2. Oral lymphomatoid granulomatosis, the first sign of a 'rare disease': a case report.
Cargini P; Civica M; Sollima L; Di Cola E; Pontecorvi E; Cutilli T
J Med Case Rep; 2014 May; 8():152. PubMed ID: 24886196
[TBL] [Abstract] [Full Text] [Related]
3. A 5-year activity report from the Oral cancer Center, Tokyo Dental College.
Yamamoto N; Sato K; Yamauchi T; Suzuki T; Osaka R; Kin M; Yoshida Y; Noguchi S; Ishizaki K; Takano M; Katakura A; Tanaka Y; Shibahara T; Takano N
Bull Tokyo Dent Coll; 2013; 54(4):265-73. PubMed ID: 24521553
[TBL] [Abstract] [Full Text] [Related]
